ytfH Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
ytfH antibody; SF4275 antibody; S4540Uncharacterized HTH-type transcriptional regulator YtfH antibody
Target Names
ytfH
Uniprot No.

Q&A

What is ytfH and why is it significant for bacterial research?

ytfH is a bacterial protein found in organisms like Escherichia coli K12 and Shigella flexneri . It belongs to a family of conserved bacterial proteins that may play roles in stress response pathways. While its exact function remains under investigation, antibodies against ytfH are valuable tools for studying bacterial physiology, stress response mechanisms, and potential pathogenic functions. The conserved nature of this protein across various bacterial species makes it particularly interesting for comparative studies of bacterial adaptation.

What are the key applications of ytfH antibodies in microbiology research?

ytfH antibodies serve several critical research functions in microbiology:

  • Detection and quantification of bacterial proteins in various experimental conditions

  • Tracking protein expression changes under environmental stressors

  • Studying protein-protein interactions involving ytfH

  • Investigating bacterial pathogenesis mechanisms where ytfH may play a role

  • Comparative studies across bacterial species to understand evolutionary conservation

How do I select the appropriate validation method for a new ytfH antibody?

When validating a new ytfH antibody, researchers should apply multiple validation strategies based on the "five pillars" approach :

  • Orthogonal methods: Compare antibody results with mass spectrometry or RNA-seq data

  • Genetic modification: Use ytfH knockout strains as negative controls

  • Independent antibodies: Verify results with multiple antibodies targeting different ytfH epitopes

  • Recombinant expression: Test against purified recombinant ytfH protein

  • Immunoprecipitation-MS: Confirm specificity through capture mass spectrometry

The combination of at least two validation methods significantly increases confidence in antibody specificity and reliability for your particular application.

How should I design experiments to characterize ytfH expression patterns in bacteria?

For robust characterization of ytfH expression:

  • Time-course studies: Monitor expression at different growth phases

    • Early log, mid-log, late log, and stationary phases

    • Sample at consistent OD600 readings for reproducibility

  • Environmental conditions: Test expression under various stressors

    • Oxidative stress (H₂O₂, paraquat)

    • Nutrient limitation

    • pH variation

    • Temperature shifts

    • Antibiotic sub-MIC exposure

  • Controls:

    • Include ytfH knockout strains as negative controls

    • Use housekeeping proteins as loading controls (e.g., RNA polymerase subunits)

    • Consider complementation studies to confirm specificity

  • Quantification: Use densitometry with appropriate normalization and statistical analysis (minimum of three biological replicates).

What is the optimal Western blot protocol for ytfH antibody applications?

Based on standard bacterial protein analysis methods, the following protocol is recommended:

  • Sample preparation:

    • Harvest bacterial cells at OD600 0.6-0.8 for mid-log phase

    • Lyse cells using sonication or commercial bacterial lysis buffers

    • Include protease inhibitors to prevent degradation

  • SDS-PAGE conditions:

    • Use 12-15% acrylamide gels for optimal resolution

    • Load 20-30 μg total protein per lane

    • Include molecular weight markers flanking your samples

  • Transfer and antibody incubation:

    • Transfer proteins to PVDF membrane (preferred over nitrocellulose for bacterial proteins)

    • Block with 5% non-fat milk or BSA in TBST for 1 hour

    • Incubate with ytfH antibody (1:500-1:2000 dilution range)

    • Wash extensively (4-5 times) with TBST

    • Use HRP-conjugated secondary antibodies with chemiluminescent detection

  • Controls and validation:

    • Include positive control (purified recombinant ytfH)

    • Include negative control (ytfH knockout strain lysate)

    • Perform peptide competition assay to confirm specificity

How can I optimize immunofluorescence protocols for ytfH localization studies?

For effective subcellular localization studies:

  • Sample fixation:

    • Fix bacterial cells with 4% paraformaldehyde (10 minutes)

    • For improved penetration, include 0.1% Triton X-100 in the fixation buffer

  • Antibody incubation:

    • Use ytfH antibody at 1:50-1:200 dilution range

    • Extend incubation time (overnight at 4°C) for weaker signals

    • Include appropriate fluorophore-conjugated secondary antibodies

  • Controls:

    • Omit primary antibody to check for non-specific binding

    • Use pre-immune serum as negative control

    • Include DAPI or other DNA stains for localizing bacteria

  • Advanced visualization:

    • Consider super-resolution microscopy for detailed localization

    • Use Z-stack acquisition for complete spatial information

    • Quantify colocalization with other bacterial markers when relevant

How can I apply next-generation sequencing (NGS) approaches to enhance ytfH antibody development?

NGS technologies can significantly improve ytfH antibody development through:

  • B-cell repertoire analysis:

    • After immunization with ytfH protein, sequence the B-cell repertoire

    • Analyze changes in the repertoire to identify B-cell clones producing anti-ytfH antibodies

    • Cluster sequences by homology to identify related antibodies

  • Implementing bioinformatic pipelines:

    • Extract antibody gene repertoire from NGS data

    • Classify components by changes in sequence frequency following immunization

    • Identify promising antibody candidates that show significant expansion

  • Validation workflow:

    • Express selected antibody candidates

    • Test reactivity to ytfH protein using ELISA and Western blot

    • Confirm specificity through competitive binding assays

This approach allows identification of multiple antibody candidates that recognize different epitopes of ytfH, providing researchers with a comprehensive antibody toolkit for various applications.

What are the methodological considerations for cross-reactivity testing of ytfH antibodies across bacterial species?

When evaluating cross-reactivity:

  • Species selection:

    • Include closely related species (within same genus)

    • Include diverse species where ytfH homologs are predicted

    • Include negative controls lacking ytfH homologs

  • Sequence analysis preparation:

    • Perform bioinformatic analysis of ytfH conservation

    • Create sequence alignment of ytfH across species

    • Identify conserved and variable regions to predict cross-reactivity

  • Experimental validation:

    • Test against purified recombinant proteins from various species

    • Perform Western blot analysis of whole-cell lysates

    • Confirm with immunoprecipitation followed by mass spectrometry

  • Data interpretation:

    SpeciesSequence homology (%)Western blot signalIP-MS confirmation
    E. coli K12100 (reference)+++Confirmed
    S. flexneri~95 (predicted)+++Confirmed
    S. typhimurium~80 (predicted)++Partial
    P. aeruginosa~60 (predicted)+/-Not detected
    B. subtilis~40 (predicted)-Not detected

    Note: This table represents a hypothetical example based on typical bacterial protein conservation patterns.

How can I characterize epitope specificity of ytfH antibodies for research applications?

For comprehensive epitope mapping:

  • Computational prediction:

    • Analyze ytfH protein sequence for immunogenic epitopes

    • Use algorithms that predict surface accessibility and antigenicity

    • Compare to known epitopes in related bacterial proteins

  • Peptide array approach:

    • Synthesize overlapping peptides spanning ytfH sequence

    • Test antibody binding to identify reactive peptides

    • Confirm with competitive binding assays

  • Structural approaches:

    • If ytfH structure is known, map epitopes to structural elements

    • Consider hydrogen-deuterium exchange mass spectrometry

    • X-ray crystallography of antibody-antigen complex for definitive mapping

  • Functional validation:

    • Generate mutants with altered epitope regions

    • Test antibody binding to confirm epitope identification

    • Assess whether antibody binding affects any known functions of ytfH

This methodical approach provides critical information about antibody specificity and potential functional interference.

How do I address inconsistent Western blot results with ytfH antibodies?

Inconsistent Western blot results can be resolved through systematic troubleshooting:

  • Protein extraction optimization:

    • Compare different lysis methods (sonication, bead-beating, enzymatic)

    • Test multiple lysis buffers with different detergents

    • Include protease inhibitors to prevent degradation

    • Ensure complete solubilization of membrane-associated proteins

  • Gel and transfer parameters:

    • Optimize acrylamide percentage for ytfH molecular weight

    • Adjust transfer conditions (voltage, time, buffer composition)

    • Consider semi-dry vs. wet transfer methods

    • Use stained markers to verify transfer efficiency

  • Antibody conditions:

    • Titrate antibody concentration (1:500 to 1:5000)

    • Test different blocking agents (milk vs. BSA)

    • Increase washing stringency to reduce background

    • Try alternative secondary antibodies

  • Validation approach:

    • Use reduced and non-reduced conditions to assess conformational epitopes

    • Compare results with alternative detection methods

    • Include recombinant ytfH protein as positive control

    • Consider batch variability in antibody production

What statistical approaches are recommended for quantifying ytfH expression changes in response to experimental conditions?

For robust statistical analysis:

  • Experimental design considerations:

    • Minimum of 3-4 biological replicates

    • Include technical replicates for Western blot analysis

    • Design factorial experiments to test multiple variables

  • Normalization strategies:

    • Normalize ytfH signal to housekeeping proteins

    • Consider total protein normalization (e.g., Ponceau staining)

    • Evaluate multiple normalization methods for consistency

  • Statistical tests:

    • For two-group comparisons: Student's t-test or Mann-Whitney U test

    • For multiple groups: ANOVA with appropriate post-hoc tests

    • For time-course data: repeated measures ANOVA or mixed models

    • Report appropriate effect sizes and confidence intervals

  • Validation methods:

    • Confirm protein-level changes with mRNA quantification

    • Use alternative antibodies targeting different ytfH epitopes

    • Consider proteomics approaches for absolute quantification

How can I distinguish between specific and non-specific binding when using ytfH antibodies in complex bacterial samples?

To distinguish specific from non-specific binding:

  • Essential controls:

    • ytfH knockout strain as negative control

    • Pre-immune serum to establish background

    • Peptide competition assay to confirm specificity

    • Secondary antibody-only control

  • Advanced validation techniques:

    • Two-dimensional Western blot for increased resolution

    • Immunoprecipitation followed by mass spectrometry identification

    • Dual labeling with independent ytfH antibodies

    • Super-resolution microscopy for co-localization studies

  • Experimental modifications:

    • Increase washing stringency gradually

    • Test multiple blocking agents to reduce background

    • Use monovalent antibody fragments (Fab) to reduce non-specific binding

    • Apply cross-adsorption against lysates from ytfH knockout strains

  • Quantitative assessment:

    • Calculate signal-to-background ratio

    • Perform densitometry of specific vs. non-specific bands

    • Use ROC curve analysis to determine optimal antibody concentration

How can language models enhance antibody specificity prediction for bacterial targets like ytfH?

Recent advances in language model applications for antibody research offer promising approaches:

  • Language model application:

    • Lightweight memory B cell language models (mBLM) have demonstrated success in predicting antibody specificity for viral targets

    • Similar approaches can be adapted for bacterial protein targets like ytfH

    • These models analyze antibody sequences to predict binding properties

  • Implementation methodology:

    • Curate datasets of known bacterial protein-antibody interactions

    • Train models on sequence features that correlate with binding specificity

    • Validate predictions experimentally with binding assays

  • Practical research application:

    • Predict cross-reactivity across bacterial species

    • Identify potential epitopes based on sequence analysis

    • Guide antibody engineering to enhance specificity

This emerging field represents a computational approach to enhance traditional antibody development methods for bacterial targets .

What innovative approaches can improve validation of ytfH antibodies in complex bacterial systems?

Advanced validation approaches include:

  • Multi-omics integration:

    • Correlate antibody binding with transcriptomics data

    • Validate with targeted proteomics approaches (PRM/MRM)

    • Integrate with bacterial interactome data

  • CRISPR-based validation systems:

    • Generate epitope-tagged versions of ytfH using CRISPR-Cas9

    • Create conditional depletion systems for ytfH

    • Engineer reporter strains for real-time monitoring

  • Novel physical validation methods:

    • Surface plasmon resonance for affinity determination

    • Hydrogen-deuterium exchange mass spectrometry for epitope mapping

    • Cryo-EM analysis of antibody-antigen complexes

  • In vivo validation approaches:

    • Evaluate antibody binding in intact bacterial cells

    • Develop cell-penetrating antibody derivatives

    • Assess functional impact using phenotypic assays

These emerging approaches promise more reliable antibody validation in complex biological systems.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.